Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TheraSense completes $50mm private placement

Executive Summary

TheraSense (diabetes) has completed a $50mm fourth round private placement led by Disetronic Holding AG--with which TheraSense has a distribution agreement--and existing investors Brentwood Associates, Crown Advisors, Dephi Ventures, Equity Group Investments, InterWest Partners, Lehman Brothers Venture Capital, Lurie Group, MedVentures, MJG Partners, and Sequoia Capital.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies